Methyl-CpG-binding Protein 2 (MECP2) Gene Mutations in an Italian Sample of Patients with Pervasive Developmental Disorder and Mental Retardation

Abstract

Methyl-CpG-binding protein 2 (MECP2) gene mutations have been identified in girls with Rett syndrome and in boys with heterogeneous neuropsychiatric disorders. Because of the limited or inconsistent data reported in literature, the role of methyl-CpG-binding protein 2 gene in the pathogenesis of mental retardation and pervasive developmental disorders needs further study. We scanned methyl-CpG-binding protein 2 gene in 99 Italian patients with pervasive developmental disorder or with nonsyndromal mental retardation. Four methyl-CpG-binding protein 2 gene mutations were found: 2 in 4 girls with Rett disorder, the others in 2 girls with mental retardation. The wide phenotypic spectrum and the variants of methyl-CpG-binding protein 2 gene, which may play an important role in gene regulation and neurodevelopment, justify the literature's interest particularly in girls.

Keywords

MECP2 mutations Rett disorder pervasive developmental disorders autism mental retardation

Get full access to this article

View all access options for this article.

References

Amir RE , Van der Veyver IB , Wan M. , Tran CQ , Francke U. , Zoghbi HY Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-188.

Lewis JD , Meehan RR , Henzel WJ , et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69:905-914.

Schanen NC , Kurczynski TW , Brunelle D. , Woodcock MM , Dure LS 4th , Percy AK Neonatal encephalopathy in two boys in families with recurrent Rett syndrome . J Child Neurol. 1998;13:229-231.

Bienvenu T. , Carrié A. , de Roux N. , et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet. 2000;9:1377-1384.

Meloni I. , Bruttini M. , Longo I. , et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000;67: 982-985.

Klauck SM , Lindsay S. , Beyer KS , Splitt M. , Burn J. , Poustka A. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet. 2002;70:1034-1037.

Dotti MT , Orrico A. , De Stefano N. , et al. A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology. 2002;58:226-230.

Lesca G. , Bernard V. , Bozon M. , et al. Mutation screening of the MECP2 gene in a large cohort of 613 fragile-X negative patients with mental retardation. Eur J Med Genet. 2007;50:200-208.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.

10.

Couvert P. , Bienvenu T. , Aquaviva C. , et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001;10:941-946.

11.

Villard L. MECP2 mutations in males. J Med Genet. 2007 ;44: 417-423.

12.

Campos M. Jr. , Abdalla CB , Santos-Rebouças CB , et al. Low significance of MECP2 mutations as a cause of mental retardation in Brazilian males. Brain Dev. 2007;29:293-297.

13.

Cohen D. , Pichard N. , Tordjman S. , et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord. 2005;35:103-116.

14.

Coutinho AM , Oliveira G. , Katz C. , et al. MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. Am J Med Genet. 2007;144B:475-483.

15.

Donzel-Javouhey A. , Thauvin-Robinet C. , Cusin V. , et al. A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. Am J Med Genet A. 2006;140:1603-1607.